MEDABLE DECENTRALIZED CLINICAL TRIAL

Serial Number 90368706
606

Registration Progress

Application Filed
Dec 9, 2020
Under Examination
Mar 1, 2022
Approved for Publication
Jan 4, 2022
Published for Opposition
Jan 4, 2022
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: MEDABLE DECENTRALIZED CLINICAL TRIAL
Previous Owner: Medable, Inc.
Classes: 035, 042, 044

Trademark Image

MEDABLE DECENTRALIZED CLINICAL TRIAL

Basic Information

Serial Number
90368706
Filing Date
December 9, 2020
Published for Opposition
January 4, 2022
Abandonment Date
October 7, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 7, 2024
Classes
035 042 044

Rights Holder

Medable, Inc.

03
Address
525 UNIVERSITY AVENUE, A70
PALO ALTO, CA 94301

Ownership History

Medable, Inc.

Original Applicant
03
PALO ALTO, CA

Medable, Inc.

Owner at Publication
03
PALO ALTO, CA

Legal Representation

Attorney
Omar M. Wadhwa

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

37 events
Date Code Type Description Documents
Oct 7, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 7, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 29, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 29, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 24, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 22, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 22, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 22, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 1, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 1, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 22, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 22, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 22, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 1, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 4, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 4, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 15, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 1, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 30, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 30, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 30, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 19, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 19, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 19, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 8, 2021 WOAG I WITHDRAWAL OF ATTORNEY GRANTED Loading...
Sep 8, 2021 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED Loading...
Jun 1, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 1, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 1, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 1, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 14, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 12, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 044
Telemedicine services

Classification

International Classes
035 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DECENTRALIZED CLINICAL TRIAL"